Thomas Shrader
Stock Analyst at BTIG
(0.69)
# 3,579
Out of 4,826 analysts
47
Total ratings
35%
Success rate
-12.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Shrader
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALDX Aldeyra Therapeutics | Maintains: Buy | $11 → $9 | $2.70 | +233.33% | 1 | Apr 7, 2025 | |
| OVID Ovid Therapeutics | Maintains: Buy | $5 → $4 | $0.30 | +1,224.50% | 3 | Mar 24, 2025 | |
| PCVX Vaxcyte | Reiterates: Buy | $160 | $34.28 | +366.74% | 4 | Feb 24, 2025 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Buy | $41 | $11.91 | +244.25% | 1 | Jan 28, 2025 | |
| ALEC Alector | Maintains: Buy | $16 → $5 | $1.16 | +331.03% | 2 | Nov 26, 2024 | |
| ATHA Athira Pharma | Downgrades: Neutral | n/a | $0.28 | - | 3 | Sep 4, 2024 | |
| ACIU AC Immune | Initiates: Buy | $8 | $1.70 | +370.59% | 1 | May 31, 2024 | |
| PMN ProMIS Neurosciences | Initiates: Buy | $8 | $0.64 | +1,150.00% | 1 | Oct 3, 2023 | |
| DTIL Precision BioSciences | Maintains: Buy | $180 → $60 | $5.67 | +958.20% | 1 | Jul 28, 2023 | |
| BHVN Biohaven | Reiterates: Buy | $24 | $22.60 | +6.19% | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $7 | $1.82 | +285.67% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $6.21 | +141.55% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $68 → $13 | $0.52 | +2,400.00% | 3 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $26 → $31 | $72.25 | -57.09% | 3 | Mar 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $10 | $2.02 | +395.05% | 2 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $22 | $1.05 | +1,995.24% | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $14 | $7.57 | +85.06% | 2 | May 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $51 | $1.60 | +3,087.50% | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $2.39 | +569.46% | 1 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.49 | - | 1 | Feb 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $15.95 | - | 2 | Oct 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $51 → $58 | $8.61 | +573.64% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.42 | +111.27% | 3 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $397 → $346 | $121.80 | +184.07% | 3 | Feb 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.05 | - | 1 | Jun 30, 2017 | |
Aldeyra Therapeutics
Apr 7, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $2.70
Upside: +233.33%
Ovid Therapeutics
Mar 24, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $0.30
Upside: +1,224.50%
Vaxcyte
Feb 24, 2025
Reiterates: Buy
Price Target: $160
Current: $34.28
Upside: +366.74%
Arcturus Therapeutics Holdings
Jan 28, 2025
Initiates: Buy
Price Target: $41
Current: $11.91
Upside: +244.25%
Alector
Nov 26, 2024
Maintains: Buy
Price Target: $16 → $5
Current: $1.16
Upside: +331.03%
Athira Pharma
Sep 4, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.28
Upside: -
AC Immune
May 31, 2024
Initiates: Buy
Price Target: $8
Current: $1.70
Upside: +370.59%
ProMIS Neurosciences
Oct 3, 2023
Initiates: Buy
Price Target: $8
Current: $0.64
Upside: +1,150.00%
Precision BioSciences
Jul 28, 2023
Maintains: Buy
Price Target: $180 → $60
Current: $5.67
Upside: +958.20%
Biohaven
Jun 6, 2023
Reiterates: Buy
Price Target: $24
Current: $22.60
Upside: +6.19%
May 25, 2023
Maintains: Buy
Price Target: $15 → $7
Current: $1.82
Upside: +285.67%
May 18, 2023
Initiates: Buy
Price Target: $15
Current: $6.21
Upside: +141.55%
Mar 28, 2023
Maintains: Buy
Price Target: $68 → $13
Current: $0.52
Upside: +2,400.00%
Mar 20, 2023
Maintains: Buy
Price Target: $26 → $31
Current: $72.25
Upside: -57.09%
Nov 14, 2022
Maintains: Buy
Price Target: $30 → $10
Current: $2.02
Upside: +395.05%
Oct 5, 2022
Maintains: Buy
Price Target: $15 → $22
Current: $1.05
Upside: +1,995.24%
May 24, 2022
Maintains: Buy
Price Target: $31 → $14
Current: $7.57
Upside: +85.06%
Apr 20, 2021
Initiates: Buy
Price Target: $51
Current: $1.60
Upside: +3,087.50%
Mar 8, 2021
Initiates: Buy
Price Target: $16
Current: $2.39
Upside: +569.46%
Feb 3, 2021
Downgrades: Neutral
Price Target: n/a
Current: $3.49
Upside: -
Oct 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $15.95
Upside: -
Sep 15, 2020
Maintains: Buy
Price Target: $51 → $58
Current: $8.61
Upside: +573.64%
Apr 3, 2020
Maintains: Buy
Price Target: $4 → $3
Current: $1.42
Upside: +111.27%
Feb 21, 2019
Downgrades: Hold
Price Target: $397 → $346
Current: $121.80
Upside: +184.07%
Jun 30, 2017
Downgrades: Hold
Price Target: n/a
Current: $1.05
Upside: -